Paper1968250
Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.
Gustafsson B and 1 other. Pharmacol Toxicol, 1990. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour. Papers, record 1968250. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1968250
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Behavior, Animal | Major topic |
| Dopamine | Major topic |
| Limbic System | Major topic |
| Piperazines | Major topic |
| Psychotropic Drugs | Major topic |
| Animals | |
| Antipsychotic Agents | |
| Catalepsy | |
| Dextroamphetamine | |
| Exploratory Behavior | |
| Female | |
| Mice | |
| Motor Activity | |
| Rats | |
| Rats, Inbred Strains | |
| Stereotyped Behavior |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 19885000 | YKP1447, A Novel Potential Atypical Antipsychotic Agent. | Korean J Physiol Pharmacol | 2009 | https://conductscience.org/library/papers/19885000 | PubMed |
| 17684494 | Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. | Mol Psychiatry | 2008 | https://conductscience.org/library/papers/17684494 | PubMed |
| 7862887 | Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. | Psychopharmacology (Berl) | 1994 | https://conductscience.org/library/papers/7862887 | PubMed |
| 7831440 | The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system. | Psychopharmacology (Berl) | 1993 | https://conductscience.org/library/papers/7831440 | PubMed |
| 2572972 | The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization. | Naunyn Schmiedebergs Arch Pharmacol | 1989 | https://conductscience.org/library/papers/2572972 | PubMed |
| 1365865 | Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats. | Psychopharmacology (Berl) | 1992 | https://conductscience.org/library/papers/1365865 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1968250
GET https://conductscience.org/api/papers/v1/1968250/authors